Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure
1. 系统已在2026-09-22 14:42:11对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1038/s41409-026-02825-0
文献链接: https://www.nature.com/articles/s41409-026-02825-0
其他信息:
出版社: Springer Science and Business Media LLC
作者: Johannes Clausen; José Antonio Pérez Simón; Martin Carré; Cristina Castilla-Llorente; David Michonneau; Alexander Schauwvlieghe; Pedro Asensi Cantó; Sylvie François; Ludovic Gabellier; Lucía López Corral; Ana Benzaquén; Hélène Labussière-Wallet; Jérome Cornillon; Raynier Devillier; Anne Huynh; Pascal Turlure; Anna Bauhofer; Hervé Jullien de Pommerol; Marion Bruelle; Imi Faghmous; Behzad Kharabi Masouleh; Emilie Plantamura; Florent Malard; Mohamad Mohty
全文下载地址: https://www.nature.com/articles/s41409-026-02825-0.pdf
